In contrast, in this study we found that PanINs lacked methylation of SOCS-1 suggesting that if loss of SOCS-1 is a selected event, it does not provide a selective advantage to a pancreatic neoplasm until the neoplasm has evolved into an invasive adenocarcinoma. This evidence concerns the gene SOCS1 and pancreatic neoplasm.